Cue Biopharma Announces First Patient Dosed in Part B Patient Expansion of CUE-101 Phase 1 Monotherapy Trial in HPV+ Second Line and Beyond HNSCC

Matt Turner
Patient Affordability

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence